07/09/2025
4:27 PM | InMed Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/24/2025
1:35 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2025
8:06 AM | InMed Pharmaceuticals (Filer)
| Form DEFA14A | |
05/16/2025
4:15 PM | InMed Pharmaceuticals (Filer)
| Form DEF 14A | |
05/13/2025
5:19 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
7:24 AM | InMed Pharmaceuticals (Filer)
| Form PRE 14A | |
04/02/2025
3:13 PM | AdvisorShares Trust (Filed by)
InMed Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
1:56 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
8:38 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
4:30 PM | InMed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/03/2025
10:20 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for INM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for InMed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/03/2025
7:49 AM | HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
9:18 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
9:54 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
10:46 AM | InMed Pharmaceuticals (Filer)
| Form 424B3 | |
01/01/2025
11:15 PM | InMed Pharmaceuticals (Filer)
| Form EFFECT | |
12/30/2024
11:16 AM | InMed Pharmaceuticals (Filer)
| Form S-1/A | |
12/23/2024
4:16 PM | InMed Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/23/2024
8:25 AM | InMed Pharmaceuticals (Issuer)
Lemerond Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:26 AM | InMed Pharmaceuticals (Issuer)
Jagpal Netta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:28 AM | InMed Pharmaceuticals (Issuer)
Johnson Shane Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:17 AM | HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:18 AM | Baldasare Bryan T (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:20 AM | ADAMS ERIC A (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:21 AM | HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:22 AM | Grove Janet P (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:24 AM | InMed Pharmaceuticals (Issuer)
WOUDENBERG MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
5:18 AM | InMed Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/19/2024
10:55 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
7:05 AM | InMed Pharmaceuticals (Subject)
YA II PN, Ltd. (Filed by)
| Form SCHEDULE 13G | |
11/12/2024
12:44 PM | AdvisorShares Trust (Filed by)
InMed Pharmaceuticals (Subject)
| Form SC 13G | |
11/05/2024
8:08 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
3:50 PM | InMed Pharmaceuticals (Filer)
| Form DEF 14A | |
10/28/2024
3:00 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
2:25 PM | InMed Pharmaceuticals (Filer)
| Form DEFA14A | |
10/24/2024
2:57 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
11:28 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
5:30 AM | InMed Pharmaceuticals (Filer)
| Form 424B3 | |
09/30/2024
12:37 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
3:10 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2024
1:04 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Trump’s #1 America First Stock (Ad) America’s industrial comeback is underway — and it’s bigger than anyone expected.
Over $5 trillion has already been pledged to restore U.S. manufacturing. Trump’s tariffs and trade pressure have set off a massive reshoring push, and the flood of investment is still gaining steam.
But while everyone’s watching the big names, one under-the-radar company holds the key tech that could make it all work — and potentially benefit the most. This could be the #1 America First stock of the decade. |
08/20/2024
1:00 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
2:08 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free INM Stock Alerts